LAUREN KISAN: Open Payments
NPI 1407633894 · MUNCIE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,191 in 52 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $1,256 · 2025 $1,191
Food & beverage: $1,091Education: $100
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 5 | $280 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $164 |
| ABBVIE INC. | 13 | $153 |
| Novartis Pharmaceuticals Corporation | 5 | $87 |
| Janssen Biotech, Inc. | 3 | $84 |
| LEO Pharma Inc. | 4 | $78 |
| PFIZER INC. | 3 | $45 |
| GENZYME CORPORATION | 2 | $44 |
| Incyte Corporation | 2 | $41 |
| UCB, Inc. | 2 | $38 |
Products named: NEMLUVIO, RINVOQ, TREMFYA, DUPIXENT, COSENTYX, ANZUPGO, CIBINQO, OPZELURA.
Industry payments across IN — which companies pay providers there.
